Detecting and Rectifying Vehicle Malicious Misbehavior for Intersection Movement Assist: A Sensor-Based Misbehavior Detection Study

2021 ◽  
pp. 036119812110513
Author(s):  
Boon Teck Ong ◽  
Joshua Kolleda ◽  
Saleh Mousa ◽  
Scott Andrews ◽  
Dennis Fleming ◽  
...  
Keyword(s):  
False Positive ◽  
Research Effort ◽  
False Negative ◽  
Field Tests ◽  
Longitudinal Direction ◽  
Third Party ◽  
Lateral Direction ◽  
Misbehavior Detection ◽  
Safety Application ◽  
Hazard Scenario

Recent developments in wireless communication technologies have led to the evolution of connectivity between vehicles. Maintaining connectivity between vehicles increases a vehicle’s awareness of other nearby vehicles, which can be used in safety applications. Identification of malicious misbehaving vehicles plays an important role in road safety. This research establishes the minimum detectable error (MDE) boundary for relative position between the observer and status vehicles (SV) using vehicle sensor and GPS error profile from field tests and established minimum standards. The results demonstrated that the MDE increases in the lateral direction (side-to-side) with the increase in relative distance between the observer and status vehicles (OV and SV) while remaining the same in the longitudinal direction (front-to-back). This research effort explores the use of Sensor-Based Misbehavior Detection (SBMD) with current specifications and the defined MDE boundary for implementation in the Intersection Movement Assist (IMA) safety application to rectify false positive and false negative hazard messages propagated by a malicious misbehaving vehicle. The simulation approach used in this research quantifies the total number of false positive/negative hazard detections received by a third-party vehicle (TPV) using the IMA safety application and assesses the capability of the OV equipped with SBMD to rectify the false positive/negative hazard detection. In cases where there was no hazard, SBMD produced an 83% to 90% improvement in the reduction of false positive hazard detections. In the cases with hazard scenario, where the SV is in the not-safe-to-cross zone, SBMD produced an 80% to 99% improvement in application performance.

scholarly journals On the ballast–sleeper interaction in the longitudinal and lateral directions

2016 ◽  
Vol 232 (2) ◽  
pp. 620-631 ◽  
Author(s):  
Antonio De Iorio ◽  
Marzio Grasso ◽  
Francesco Penta ◽  
Giovanni Pio Pucillo ◽  
Stefano Rossi ◽  
...  
Keyword(s):  
Ad Hoc ◽  
Mechanical Design ◽  
Field Tests ◽  
Longitudinal Direction ◽  
Detailed Knowledge ◽  
Research Activity ◽  
Lateral Direction ◽  
Technical Literature ◽  
Testing Conditions ◽  
Ballast Resistance

In service, railway tracks must withstand the transverse and longitudinal forces that are caused by running vehicles and thermal loads. The mechanical design that adopts any of the track models available in the technical literature requires that the strength of the track is fully characterised. In this paper, the results of an experimental research activity on the sleeper–ballast resistance along the lateral and the longitudinal directions are reported and discussed. In particular, the work is aimed at identifying the strength contributions offered by the base, the ballast between the sleepers, and the ballast shoulder to the global resistance of the track in the horizontal plane. These quantities were experimentally determined by means of an ad hoc system designed by the authors. Field tests were carried out on a series of track sections that were built to simulate scenarios in which the ballast was removed from the crib and/or the shoulder. The results of this study indicate that the strength percent contributions from the crib, the sleeper base, and the shoulder are, respectively, equal to about 50%, 25%, and 25% in the lateral direction, and 60%, 30%, and 10% in the longitudinal direction. Moreover, the comparison of the acquired data with literature results reveals that a detailed knowledge about the testing conditions and the activated ballast failure mechanisms is needed in order to correctly use the test data for the design purpose.

Critical Evaluation of Impedance Phlebography for the Diagnosis of Deep Vein Thrombosis

1974 ◽  
Vol 31 (02) ◽  
pp. 273-278
Author(s):  
Kenneth K Wu ◽  
John C Hoak ◽  
Robert W Barnes ◽  
Stuart L Frankel
Keyword(s):  
Deep Vein Thrombosis ◽  
False Positive ◽  
False Negative ◽  
Critical Evaluation ◽  
Original Method ◽  
Vein Thrombosis ◽  
Negative Results ◽  
False Negative Results ◽  
Deep Vein ◽  
Positive Results

SummaryIn order to evaluate its daily variability and reliability, impedance phlebography was performed daily or on alternate days on 61 patients with deep vein thrombosis, of whom 47 also had 125I-fibrinogen uptake tests and 22 had radiographic venography. The results showed that impedance phlebography was highly variable and poorly reliable. False positive results were noted in 8 limbs (18%) and false negative results in 3 limbs (7%). Despite its being simple, rapid and noninvasive, its clinical usefulness is doubtful when performed according to the original method.

scholarly journals Preliminary Results of MyCog, a Brief Assessment for the Detection of Cognitive Impairment in Primary Care

2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 259-260
Author(s):  
Laura Curtis ◽  
Lauren Opsasnick ◽  
Julia Yoshino Benavente ◽  
Cindy Nowinski ◽  
Rachel O’Conor ◽  
...  
Keyword(s):  
Primary Care ◽  
Cognitive Impairment ◽  
Cognitive Aging ◽  
False Positive ◽  
False Positive Rate ◽  
False Negative ◽  
False Negative Rate ◽  
Self Report ◽  
Card Sorting ◽  
Primary Care Settings

Abstract Early detection of Cognitive impairment (CI) is imperative to identify potentially treatable underlying conditions or provide supportive services when due to progressive conditions such as Alzheimer’s Disease. While primary care settings are ideal for identifying CI, it frequently goes undetected. We developed ‘MyCog’, a brief technology-enabled, 2-step assessment to detect CI and dementia in primary care settings. We piloted MyCog in 80 participants 65 and older recruited from an ongoing cognitive aging study. Cases were identified either by a documented diagnosis of dementia or mild cognitive impairment (MCI) or based on a comprehensive cognitive battery. Administered via an iPad, Step 1 consists of a single self-report item indicating concern about memory or other thinking problems and Step 2 includes two cognitive assessments from the NIH Toolbox: Picture Sequence Memory (PSM) and Dimensional Change Card Sorting (DCCS). 39%(31/80) participants were considered cognitively impaired. Those who expressed concern in Step 1 (n=52, 66%) resulted in a 37% false positive and 3% false negative rate. With the addition of the PSM and DCCS assessments in Step 2, the paradigm demonstrated 91% sensitivity, 75% specificity and an area under the ROC curve (AUC)=0.82. Steps 1 and 2 had an average administration time of <7 minutes. We continue to optimize MyCog by 1) examining additional items for Step 1 to reduce the false positive rate and 2) creating a self-administered version to optimize use in clinical settings. With further validation, MyCog offers a practical, scalable paradigm for the routine detection of cognitive impairment and dementia.

Evaluation of Positive T- and B-Cell Gene Rearrangement Studies Among Patients Without a Definitive Diagnosis by Other Assays

2019 ◽  
Vol 152 (Supplement_1) ◽  
pp. S35-S36
Author(s):  
Hadrian Mendoza ◽  
Christopher Tormey ◽  
Alexa Siddon
Keyword(s):  
T Cell ◽  
False Positive ◽  
Gene Rearrangement ◽  
Hematologic Malignancy ◽  
False Negative ◽  
False Positives ◽  
False Negatives ◽  
True Negative ◽  
Flow Cytometric ◽  
Pathology Reports

Abstract In the evaluation of bone marrow (BM) and peripheral blood (PB) for hematologic malignancy, positive immunoglobulin heavy chain (IG) or T-cell receptor (TCR) gene rearrangement results may be detected despite unrevealing results from morphologic, flow cytometric, immunohistochemical (IHC), and/or cytogenetic studies. The significance of positive rearrangement studies in the context of otherwise normal ancillary findings is unknown, and as such, we hypothesized that gene rearrangement studies may be predictive of an emerging B- or T-cell clone in the absence of other abnormal laboratory tests. Data from all patients who underwent IG or TCR gene rearrangement testing at the authors’ affiliated VA hospital between January 1, 2013, and July 6, 2018, were extracted from the electronic medical record. Date of testing; specimen source; and morphologic, flow cytometric, IHC, and cytogenetic characterization of the tissue source were recorded from pathology reports. Gene rearrangement results were categorized as true positive, false positive, false negative, or true negative. Lastly, patient records were reviewed for subsequent diagnosis of hematologic malignancy in patients with positive gene rearrangement results with negative ancillary testing. A total of 136 patients, who had 203 gene rearrangement studies (50 PB and 153 BM), were analyzed. In TCR studies, there were 2 false positives and 1 false negative in 47 PB assays, as well as 7 false positives and 1 false negative in 54 BM assays. Regarding IG studies, 3 false positives and 12 false negatives in 99 BM studies were identified. Sensitivity and specificity, respectively, were calculated for PB TCR studies (94% and 93%), BM IG studies (71% and 95%), and BM TCR studies (92% and 83%). Analysis of PB IG gene rearrangement studies was not performed due to the small number of tests (3; all true negative). None of the 12 patients with false-positive IG/TCR gene rearrangement studies later developed a lymphoproliferative disorder, although 2 patients were later diagnosed with acute myeloid leukemia. Of the 14 false negatives, 10 (71%) were related to a diagnosis of plasma cell neoplasms. Results from the present study suggest that positive IG/TCR gene rearrangement studies are not predictive of lymphoproliferative disorders in the context of otherwise negative BM or PB findings. As such, when faced with equivocal pathology reports, clinicians can be practically advised that isolated positive IG/TCR gene rearrangement results may not indicate the need for closer surveillance.

Sign in / Sign up

Export Citation Format

Share Document